Suppr超能文献

干细胞疗法用于骨科疾病(包括骨关节炎和骨缺损)的疗效与安全性。

Efficacy and Safety of Stem Cell Therapy for Orthopedic Conditions, Including Osteoarthritis and Bone Defects.

作者信息

Raza Tauseef, Hassan Syed Muhammad Tayyab, Hashmi Abdul Munaf S, Zia Osama Bin, Inam Muhammad, Abidi Syed Abdur Rub, Kashif Muhammad, Adeel Muhammad

机构信息

Orthopedics, Khyber Medical University Institute of Medical Sciences, Kohat, PAK.

Orthopedic Surgery, Dar As Sihha Medical Center, Dammam, SAU.

出版信息

Cureus. 2024 Jul 6;16(7):e63980. doi: 10.7759/cureus.63980. eCollection 2024 Jul.

Abstract

INTRODUCTION

Orthopedic conditions like osteoarthritis and bone defects pose significant challenges due to their impact on individuals' quality of life. Traditional treatments often provide only symptomatic relief, necessitating alternative therapies for long-term management. Stem cell therapy has grabbed attention for its regenerative and immunomodulatory properties, offering potential for tissue repair and functional restoration.

OBJECTIVE

This study aims to assess the efficacy and safety of stem cell therapy for orthopedic conditions, specifically osteoarthritis and bone defects.

MATERIALS AND METHODS

A retrospective cross-sectional study analyzed data from patients who underwent stem cell therapy for osteoarthritis or bone defects between January and September 2023. Outcome measures focused on pain and function improvements using tools such as Visual Analog Scale (VAS) and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), alongside radiographic assessments. Adverse events, range of motion, quality of life, and demographic factors were also examined. Data were collected from electronic medical records while maintaining patient confidentiality. Descriptive statistics using SPSS (IBM Corp., Armonk, NY, USA) were employed to analyze patient characteristics, treatment variables, and outcomes, with statistical significance determined using Chi-square test and Independent t-test.

RESULTS

Out of 50 individuals, the majority, i.e., 35 (or 70%), were diagnosed with osteoarthritis, while the remaining 15 (30%) had bone defects. Treatment outcomes showed significant improvements in pain and function, with a decrease in mean VAS and WOMAC scores at the six-month follow-up. Seven participants (28%) reported adverse events, and two participants (8%) experienced serious adverse events.

CONCLUSION

Stem cell therapy shows promise for treating orthopedic conditions like osteoarthritis and bone defects. While demonstrating efficacy in pain management and functional improvement, safety considerations warrant further investigation and optimization of treatment protocols. Future research should focus on refining stem cell therapy techniques and addressing safety concerns to maximize its therapeutic potential in orthopedic practice.

摘要

引言

骨关节炎和骨缺损等骨科疾病因其对个人生活质量的影响而带来重大挑战。传统治疗往往只能缓解症状,因此需要替代疗法进行长期管理。干细胞疗法因其再生和免疫调节特性而备受关注,为组织修复和功能恢复提供了潜力。

目的

本研究旨在评估干细胞疗法对骨科疾病,特别是骨关节炎和骨缺损的疗效和安全性。

材料与方法

一项回顾性横断面研究分析了2023年1月至9月期间接受干细胞疗法治疗骨关节炎或骨缺损患者的数据。结局指标重点关注使用视觉模拟量表(VAS)和西安大略和麦克马斯特大学骨关节炎指数(WOMAC)等工具评估的疼痛和功能改善情况,同时进行影像学评估。还检查了不良事件、活动范围、生活质量和人口统计学因素。数据从电子病历中收集,同时保持患者的保密性。使用SPSS(美国纽约州阿蒙克市IBM公司)进行描述性统计,以分析患者特征、治疗变量和结局,使用卡方检验和独立t检验确定统计学意义。

结果

在50名个体中,大多数(即35名,占70%)被诊断为骨关节炎,其余15名(30%)有骨缺损。治疗结果显示疼痛和功能有显著改善,在六个月的随访中平均VAS和WOMAC评分有所下降。七名参与者(28%)报告了不良事件,两名参与者(8%)经历了严重不良事件。

结论

干细胞疗法在治疗骨关节炎和骨缺损等骨科疾病方面显示出前景。虽然在疼痛管理和功能改善方面显示出疗效,但安全问题值得进一步研究并优化治疗方案。未来的研究应侧重于改进干细胞疗法技术并解决安全问题,以最大限度地发挥其在骨科实践中的治疗潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89be/11299758/ca70f5a5a411/cureus-0016-00000063980-i01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验